Fingerprint
Dive into the research topics of 'A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage
Chad W. Washington, Colin P. Derdeyn, Rajat Dhar, Eric J. Arias, Michael R. Chicoine, Dewitte T. Cross, Ralph G. Dacey, Byung Hee Han, Christopher J. Moran, Keith M. Rich, Ananth K. Vellimana, Gregory J. Zipfel
- Institute of Clinical and Translational Sciences (ICTS)
- Department of Neurosurgery
- Siteman Cancer Center
- Center for the Investigation of Membrane Excitability Diseases
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Section of Neurocritical Care
- Section of Neuroradiology
- Washington University School of Medicine
- DBBS - Neurosciences
- Hope Center for Neurological Disorders
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Neurofibromatosis (NF) Center
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations